ZR
Ziyaur Rahman
Texas A&M University, US Food and Drug Administration, Jamia Hamdard Faculty of Pharmacy, Texas A&M University Health Sciences Center School of Graduate Studies
Research areas: Pharmacology, Toxicology and Pharmaceutics · Pharmaceutical Science · Drug Solubulity and Delivery Systems · Analytical Methods in Pharmaceuticals · Advanced Drug Delivery Systems
Employment
-
Texas A&M University Associate Professor2016 - Present
-
US Food and Drug Administration Scientist and Reviewer2012 - 2016
-
Texas A&M University Health Sciences Center School of Graduate Studies Faculty2011 - 2012
-
US Food and Drug Administration ORISE fellow2008 - 2011
-
University of Mississippi Postdoctoral Associate2007 - 2008
-
Dabur Research Foundation Scientist2006 - 2007
-
Torrent Research and Development Centre Scientist2005 - 2006
Education
-
Jamia Hamdard Faculty of Pharmacy Ph.D. (Pharmaceutics)2003 - 2005
-
Jamia Hamdard Faculty of Pharmacy M.S. (Pharmaceutics)2000 - 2002
-
Jamia Hamdard Faculty of Pharmacy B.S. (Pharmacy)1996 - 2000
Projects & Funding
-
Evaluation of Potential Application of Sucrose Acetate Isobutyrate (SAIB) in Combination with Following Polymers in the Development of Abuse Deterrent Formulations of Opiod Drugs Eastman Chemical Company2018 - 2019
-
Methods for Evaluation of Abuse Deterrence via Smoking and Vaping Food and Drug Administration2018 - 2019
-
Dissolution of smokeless tobacco products U.S. Food and Drug Administration2018 - 2020
-
Pharmaceutical Quality Scorecard Development U.S. Food and Drug Administration2017 - 2018
-
Performance evaluation of polymers blend as an enteric coating material for pharmaceutical use Eastman Chemical Company2017 - 2018
Publications (126)
- Patients In-Use Stability and Safety of Repacked Delayed-Release Tablets of a Narrow Therapeutic Index Antiseizure Agent Save
- Process Analytical Technology Integration in 3D Printing Processes: Benefits and Challenges Save
- Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations Save
- Addressing printability of poorly flowable drug by wet granulation: understanding interplays of formulation and process variables on critical quality attributes of sulfadiazine printlets Save
- Stability Assessment of FDA Approved Varenicline Tartrate Products for Critical Quality Attributes – N-Nitroso Varenicline, Solid Form, and Dissolution Save
- Appropriateness of Dissolution Methods on Evaluation of Digoxin Product Quality Save
- Development and Characterization of Printlets of Lamivudine for Pediatric Patients Using Selective Laser Sintering Save
- A Comparative Study in Metformin Tablet Quality Assessment: LC‐MS and LC‐MS/MS Method Quantification of N‐Nitroso‐Dimethylamine in the Presence of Dimethyl Formamide Save
- Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients Save
- Oral Bioavailability Enhancement of Poorly Soluble Drug by Amorphous Solid Dispersion Using Sucrose Acetate Isobutyrate Save
- Risk-Based Approach for Defining Retest Dates for Active Pharmaceutical Ingredients and Excipients Save
- Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy Save
- In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery Save
- Effect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection Save
- Central composite designs and their applications in pharmaceutical product development Save
- Coating characterization by hyperspectroscopy and predictive dissolution models of tablets coated with blends of cellulose acetate and cellulose acetate phthalate Save
- Development of Stable Amorphous Solid Dispersion and Quantification of Crystalline Fraction of Lopinavir by Spectroscopic-chemometric Methods Save
- Opportunities and challenges of selective laser sintering 3D printing in personalized pharmaceutical manufacturing Save
- Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products. Save
- Salt Engineering of Aripiprazole with Polycarboxylic Acids to Improve Physicochemical Properties. Save